andrew lewisPharma pro Andrew Lewis has moved to Astellas to head communications for the drug maker's global medical & development unit.

Lewis led public affairs and global communications for the therapies group at AbbVie, which is merging with Shire in a $54B "inversion" deal.

Northbrook, Ill.-based Astellas has revamped its communications since the hire of chief communications officer Winton last October. The company, the US unit of Japan's Astellas Pharma that does $2.3B in North American sales per year, brought in PhRMA's Karl Uhlendorf in June.

Lewis, in the newly created post, guides internal and external comms. for the GMD operation that includes clinical development, regulatory and medical affairs, and "pharmacovigilance" (drug safety).

He previously directed international affairs at Abbott Laboratories and held corporate communications posts at Baxter and Elan Pharmaceuticals. He is also a former VP at Dezenhall Resources.